Cargando…

mTOR Activation in Liver Tumors Is Associated with Metabolic Syndrome and Non-Alcoholic Steatohepatitis in Both Mouse Models and Humans

Non-alcoholic steatohepatitis (NASH) can cause liver fibrosis and cirrhosis, with final progression to hepatocellular carcinoma (HCC) in some cases. Various factors have been suggested to be involved in the development of NASH. Considering the many possible contributing factors, we postulated that m...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okuno, Takahiro, Kakehashi, Anna, Ishii, Naomi, Fujioka, Masaki, Gi, Min, Wanibuchi, Hideki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315895/ https://www.ncbi.nlm.nih.gov/pubmed/30469530 http://dx.doi.org/10.3390/cancers10120465

Ejemplares similares

Accumulation of 8-hydroxydeoxyguanosine, L-arginine and Glucose Metabolites by Liver Tumor Cells Are the Important Characteristic Features of Metabolic Syndrome and Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2020)

Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas
por: Kakehashi, Anna, et al.
Publicado: (2017)

Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2017)

Progression of Hepatic Adenoma to Carcinoma in Ogg1 Mutant Mice Induced by Phenobarbital
por: Kakehashi, Anna, et al.
Publicado: (2017)

Cache Domain Containing 1 Is a Novel Marker of Non-Alcoholic Steatohepatitis-Associated Hepatocarcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2021)

Ethanol-Extracted Brazilian Propolis Exerts Protective Effects on Tumorigenesis in Wistar Hannover Rats
por: Kakehashi, Anna, et al.
Publicado: (2016)

Recent Insights into the Biomarkers, Molecular Targets and Mechanisms of Non-Alcoholic Steatohepatitis-Driven Hepatocarcinogenesis
por: Kakehashi, Anna, et al.
Publicado: (2023)

Diphenylarsinic acid exerts promotion effects on hepatobiliary carcinogenesis in a rat medium-term multiorgan carcinogenicity bioassay
por: Ishii, Naomi, et al.
Publicado: (2016)

Pueraria mirifica Exerts Estrogenic Effects in the Mammary Gland and Uterus and Promotes Mammary Carcinogenesis in Donryu Rats
por: Kakehashi, Anna, et al.
Publicado: (2016)

Evaluation of the Modifying Effect of Inhalation of Mainstream Cigarette Smoke on Mouse Bladder Carcinogenesis
por: Kato, Minoru, et al.
Publicado: (2013)

Quantitative Approaches to Assess Key Carcinogenic Events of Genotoxic Carcinogens
por: Fukushima, Shoji, et al.
Publicado: (2018)

A chronic toxicity study of diphenylarsinic acid in the drinking water of C57BL/6J mice for 52 weeks
por: Yamaguchi, Takashi, et al.
Publicado: (2019)

CD44 variant 9 is a potential biomarker of tumor initiating cells predicting survival outcome in hepatitis C virus‐positive patients with resected hepatocellular carcinoma
por: Kakehashi, Anna, et al.
Publicado: (2016)

Evaluation of the Subchronic Toxicity of Dietary Administered Equisetum arvense in F344 Rats
por: Tago, Yoshiyuki, et al.
Publicado: (2010)

Steroid sulfatase promotes invasion through epithelial-mesenchymal transition and predicts the progression of bladder cancer
por: Shimizu, Yasuomi, et al.
Publicado: (2018)

Enhanced Urinary Bladder, Liver and Colon Carcinogenesis in Zucker Diabetic Fatty Rats in a Multiorgan Carcinogenesis Bioassay: Evidence for Mechanisms Involving Activation of PI3K Signaling and Impairment of p53 on Urinary Bladder Carcinogenesis
por: Ishii, Naomi, et al.
Publicado: (2011)

Cyclopamine and Rapamycin Synergistically Inhibit mTOR Signalling in Mouse Hepatocytes, Revealing an Interaction of Hedgehog and mTor Signalling in the Liver
por: Spormann, Luise, et al.
Publicado: (2020)

Liver-adipose tissue crosstalk in alcohol-associated liver disease: The role of mTOR
por: Rodriguez, Yssa, et al.
Publicado: (2022)

Role of deltaNp63(pos) CD44v(pos) cells in the development of N‐nitroso‐tris‐chloroethylurea‐induced peripheral‐type mouse lung squamous cell carcinomas
por: Yamano, Shotaro, et al.
Publicado: (2016)

Hepatocellular loss of mTOR aggravates tumor burden in nonalcoholic steatohepatitis-related HCC
por: Kroh, Andreas, et al.
Publicado: (2023)

Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
por: Fernández-Ramos, David, et al.
Publicado: (2020)

Carbonic anhydrase 2 is a novel invasion‐associated factor in urinary bladder cancers
por: Tachibana, Hirokazu, et al.
Publicado: (2017)

The carbonic anhydrase inhibitor acetazolamide inhibits urinary bladder cancers via suppression of β‐catenin signaling
por: Matsue, Taisuke, et al.
Publicado: (2022)

Valerian Inhibits Rat Hepatocarcinogenesis by Activating GABA(A) Receptor-Mediated Signaling
por: Kakehashi, Anna, et al.
Publicado: (2014)

Anti‐PD‐L1 treatment enhances antitumor effect of everolimus in a mouse model of renal cell carcinoma
por: Hirayama, Yukiyoshi, et al.
Publicado: (2016)

Vascularization in mTOR Mouse Mutants: An Effort Not in Vein
por: Elziny, Soad, et al.
Publicado: (2023)

mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer
por: Gao, Wei, et al.
Publicado: (2012)

DNA Methylation Aberrations in Dimethylarsinic Acid-Induced Bladder Carcinogenesis
por: Yamamoto, Tomoki, et al.
Publicado: (2023)

Liver Fibrogenesis in Non-Alcoholic Steatohepatitis
por: Bian, Zhaolian, et al.
Publicado: (2012)

Myelination and mTOR
por: Figlia, Gianluca, et al.
Publicado: (2017)

mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
por: Zou, Zhilin, et al.
Publicado: (2020)

A carcinogenicity study of diphenylarsinic acid in C57BL/6J mice in drinking water for 78 weeks
por: Yamaguchi, Takashi, et al.
Publicado: (2022)

Protocol for the assessment of mTOR activity in mouse primary hepatocytes
por: Plata-Gómez, Ana Belén, et al.
Publicado: (2021)

Additive effects of inhibiting both mTOR and glutamine metabolism on the arthritis in SKG mice
por: Ueda, Yo, et al.
Publicado: (2019)

mTOR Signaling in Cancer and mTOR Inhibitors in Solid Tumor Targeting Therapy
por: Tian, Tian, et al.
Publicado: (2019)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Escaping mTOR inhibition for cancer therapy: Tumor suppressor functions of mTOR
por: Villar, Victor H., et al.
Publicado: (2017)

Overcoming mTOR Resistance Mutations with a New Generation mTOR Inhibitor
por: Rodrik-Outmezguine, Vanessa S., et al.
Publicado: (2016)

The Role of mTOR Inhibitors in Liver Transplantation: Reviewing the Evidence
por: Klintmalm, Goran B., et al.
Publicado: (2014)

The Upstream Pathway of mTOR-Mediated Autophagy in Liver Diseases
por: Wang, Haojie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2hre7201u00mefd7g7ns8ut9ov